Skip to main content
. 2020 Aug 4;22(4):3073–3080. doi: 10.3892/mmr.2020.11416

Figure 2.

Figure 2.

Effects of fluoxetine on lipid metabolism in rats with STZ-induced diabetes. (A) Fluoxetine suppressed the levels of triglyceride in rats with STZ-induced diabetes. (B) Fluoxetine reduced the levels of total cholesterol in rats with STZ-induced diabetes. (C) Effects of fluoxetine on the expression levels of glucose metabolism-associated proteins in rats with STZ-induced diabetes. #P<0.05 vs. the control group. *P<0.05 vs. the DM group. DM, diabetes mellitus; FAS, fatty acid synthase; H-fluoxetine, 20 mg/kg fluoxetine; L-fluoxetine, 40 mg/kg fluoxetine; LPL, lipoprotein lipase; PPARγ, peroxisome proliferator-activated receptor γ; SREBP-1c, sterol regulatory element-binding protein 1-c; STZ, streptozotocin.